SABBY MANAGEMENT, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$946,000
-64.4%
824
-99.5%
0.21%
-38.8%
Q3 2018$2,660,000
+11.3%
156,913
-6.7%
0.34%
-7.9%
Q2 2018$2,389,000
-55.8%
168,239
-40.8%
0.37%
+14.6%
Q1 2018$5,402,000
+2699.0%
284,272
+349.8%
0.32%
+2827.3%
Q4 2016$193,000
+27.0%
63,204
+92.7%
0.01%
+83.3%
Q3 2016$152,000
-81.3%
32,804
-75.6%
0.01%
-85.4%
Q1 2016$814,000
-32.0%
134,500
+2.6%
0.04%
-37.9%
Q4 2015$1,197,000
-51.2%
131,100
-69.9%
0.07%
-34.7%
Q3 2015$2,455,000
-31.5%
435,225
+34.6%
0.10%
-22.9%
Q2 2015$3,586,000
-12.0%
323,390
+24.5%
0.13%
-22.9%
Q1 2015$4,073,000
-8.8%
259,741
-11.5%
0.17%
+20.6%
Q4 2014$4,464,000
-1.5%
293,500
-30.1%
0.14%
-19.0%
Q3 2014$4,531,000
-33.1%
420,123
-5.2%
0.17%
-40.0%
Q2 2014$6,769,000
+111.2%
443,286
+150.1%
0.29%
+61.1%
Q1 2014$3,205,000177,2650.18%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders